Payal B. Watchmaker

Dec 5, 2024 | science.org | Milos S. Simic |Nishith Reddy |Nicholas Dulvy |Payal B. Watchmaker

Editor’s summaryCells modified outside of the body and then reintroduced provide an advantage over most small-molecule therapeutics in that cells can be designed to recognize target molecules in specific tissues and then act locally. Two studies now demonstrate advances in cell engineering for treating human disease (see the Perspective by Davila and Brentjens). Reddy et al.